IRadimed Corporation
IRMD
$69.57
-$1.12-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 77.64M | 75.15M | 73.24M | 71.31M | 69.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 77.64M | 75.15M | 73.24M | 71.31M | 69.48M |
| Cost of Revenue | 17.88M | 17.35M | 16.89M | 16.30M | 15.84M |
| Gross Profit | 59.75M | 57.81M | 56.35M | 55.00M | 53.65M |
| SG&A Expenses | 33.27M | 32.56M | 31.59M | 30.80M | 29.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.83M | 52.51M | 51.28M | 49.98M | 48.04M |
| Operating Income | 23.81M | 22.65M | 21.96M | 21.32M | 21.44M |
| Income Before Tax | 26.04M | 24.98M | 24.28M | 23.61M | 23.60M |
| Income Tax Expenses | 5.38M | 5.19M | 5.04M | 4.99M | 4.96M |
| Earnings from Continuing Operations | 20.66 | 19.78 | 19.23 | 18.63 | 18.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.66M | 19.78M | 19.23M | 18.63M | 18.64M |
| EBIT | 23.81M | 22.65M | 21.96M | 21.32M | 21.44M |
| EBITDA | 24.60M | 23.43M | 22.78M | 22.15M | 22.26M |
| EPS Basic | 1.63 | 1.56 | 1.52 | 1.47 | 1.48 |
| Normalized Basic EPS | 1.28 | 1.23 | 1.20 | 1.17 | 1.17 |
| EPS Diluted | 1.62 | 1.55 | 1.50 | 1.46 | 1.46 |
| Normalized Diluted EPS | 1.27 | 1.22 | 1.19 | 1.16 | 1.16 |
| Average Basic Shares Outstanding | 50.78M | 50.73M | 50.68M | 50.62M | 50.55M |
| Average Diluted Shares Outstanding | 51.25M | 51.17M | 51.10M | 51.03M | 50.98M |
| Dividend Per Share | 0.66 | 0.64 | 0.47 | 0.45 | 0.30 |
| Payout Ratio | 39.33% | 39.74% | 71.11% | 63.22% | 52.97% |